Pathway Capital Management LP Buys Shares of 177,770 Tempus AI, Inc. (NASDAQ:TEM)

Pathway Capital Management LP purchased a new position in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 177,770 shares of the company's stock, valued at approximately $8,576,000. Tempus AI comprises 49.4% of Pathway Capital Management LP's investment portfolio, making the stock its biggest position. Pathway Capital Management LP owned approximately 0.10% of Tempus AI as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Sumitomo Mitsui Trust Group Inc. raised its stake in Tempus AI by 31.4% during the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company's stock worth $205,284,000 after buying an additional 1,016,384 shares during the period. Franklin Resources Inc. increased its stake in shares of Tempus AI by 240.5% during the 4th quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company's stock worth $93,251,000 after purchasing an additional 1,950,862 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Tempus AI by 86,947.2% during the 4th quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company's stock worth $55,836,000 after acquiring an additional 1,651,996 shares during the period. Norges Bank bought a new position in shares of Tempus AI in the fourth quarter valued at about $34,681,000. Finally, Alliancebernstein L.P. raised its holdings in Tempus AI by 40.3% in the 4th quarter. Alliancebernstein L.P. now owns 945,133 shares of the company's stock valued at $31,908,000 after acquiring an additional 271,591 shares during the period. Institutional investors and hedge funds own 24.22% of the company's stock.

Insider Activity at Tempus AI

In other Tempus AI news, COO Ryan Fukushima sold 5,000 shares of the firm's stock in a transaction dated Monday, July 7th. The shares were sold at an average price of $60.00, for a total transaction of $300,000.00. Following the sale, the chief operating officer directly owned 145,000 shares of the company's stock, valued at $8,700,000. This trade represents a 3.33% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Eric P. Lefkofsky sold 250,000 shares of Tempus AI stock in a transaction on Tuesday, June 17th. The shares were sold at an average price of $70.07, for a total value of $17,517,500.00. Following the completion of the sale, the chief executive officer directly owned 9,357,283 shares of the company's stock, valued at approximately $655,664,819.81. This represents a 2.60% decrease in their position. The disclosure for this sale can be found here. Insiders sold 612,522 shares of company stock worth $41,600,238 in the last ninety days. Company insiders own 27.60% of the company's stock.

Analyst Upgrades and Downgrades

TEM has been the subject of a number of recent research reports. Guggenheim upped their target price on Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a report on Monday, June 30th. Bank of America boosted their price target on Tempus AI from $68.00 to $70.00 and gave the company a "neutral" rating in a research note on Wednesday, June 25th. Piper Sandler boosted their target price on Tempus AI from $55.00 to $70.00 and gave the company a "neutral" rating in a research report on Thursday, May 15th. Morgan Stanley boosted their target price on shares of Tempus AI from $60.00 to $65.00 and gave the stock an "overweight" rating in a research report on Friday, May 9th. Finally, BTIG Research assumed coverage on shares of Tempus AI in a report on Monday, April 21st. They set a "buy" rating and a $60.00 price objective on the stock. Six analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $65.09.

Tempus AI Price Performance

TEM traded up $1.08 during trading on Monday, reaching $62.06. The company's stock had a trading volume of 1,736,896 shares, compared to its average volume of 7,706,599. The firm has a fifty day simple moving average of $63.06 and a two-hundred day simple moving average of $55.95. The company has a market cap of $10.74 billion and a price-to-earnings ratio of -7.96. The company has a quick ratio of 1.56, a current ratio of 1.71 and a debt-to-equity ratio of 2.45. Tempus AI, Inc. has a 1 year low of $31.36 and a 1 year high of $91.45.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share for the quarter, beating the consensus estimate of ($0.27) by $0.03. The firm had revenue of $255.74 million during the quarter, compared to the consensus estimate of $248.13 million. Tempus AI had a negative net margin of 88.27% and a negative return on equity of 533.21%. The company's revenue for the quarter was up 75.4% compared to the same quarter last year. As a group, analysts anticipate that Tempus AI, Inc. will post -6.15 EPS for the current year.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.